Contact Us
EN
/
中
Company
People
Pipeline
Our Pipeline
Partnering
In-Licensing
News & Events
careers
CONTACT US
EN
/
中
Borderless Innovation
guided by
Global Intelligence
About Inmagene
Learn more
Our pipeline
Inmagene has a robust and growing pipeline, focused on treating immunological diseases.
Learn more
Clinical Trials
IMG-004 and IMG-007 are completing global phase I studies and IMG-008 is entering Phase I.
Learn more
Partnering
Inmagene has formed strategic partnerships with Affibody AB and HUTCHMED (Nasdaq/AIM: HCM) to develop highly innovative drug candidates.
Inmagene has several assets with strong differentiations available for partnering.
Learn more
News and Events
View all news
